Unknown

Dataset Information

Management of stage II seminoma: a contemporary UK perspective.


ABSTRACT:

Background and aims

Testicular Germ Cell Tumours (TGCTs) are the commonest young adult male cancer, with excellent survival outcomes even with metastatic disease. Chemotherapy, radiotherapy, and surgery are international guideline-dictated standard of care (SOC) treatments for International Germ Cell Cancer Collaborative Group (IGCCCG) "good risk" TGCT, but are associated with significant toxicities. Therapy de-escalation aims to reduce treatment morbidity whilst preserving cure rates, and has been adopted by some centres for stage IIA/B seminoma. Here, we report on the contemporary UK treatment landscape for stage IIA/B seminoma.

Methods

A questionnaire-based survey of NHS England-designated specialist cancer centres hosting supra-regional specialist multi-disciplinary team

SUBMITTER: Alifrangis C 

PROVIDER: S-EPMC9379299 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature